Search results
Results from the WOW.Com Content Network
Thoratec Laboratories develops, manufactures and markets proprietary medical devices The company will unveil its latest earnings on Monday, Jan. 30. Thoratec Earnings Preview
The successful prediction of a stock's future price could yield significant profit. The efficient market hypothesis suggests that stock prices reflect all currently available information and any price changes that are not based on newly revealed information thus are inherently unpredictable. Others disagree and those with this viewpoint possess ...
Nearly one year ago, I made four predictions about the stock market in 2024. The Fed indeed cut rates in Q4, but stocks didn't jump as much as I anticipated. Here are my five predictions for the ...
For premium support please call: 800-290-4726 more ways to reach us
The S&P 500's Shiller price-to-earnings (P/E) Ratio, also known as the cyclically adjusted P/E Ratio , ended Dec. 27 at 37.94, which is a stone's throw from its 2024 high and the third-highest ...
With the 2001 Thermo Cardiosystems merger, Thoratec acquired the HeartMate Left Ventricular Assist System, an implanted VAD for end-stage heart patients. A landmark three-year study of 129 patients at 22 major medical centers, called REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) and published in November 2001, found that the HeartMate VE ...
The 10-second takeaway For the quarter ended Sep. 29 (Q3), Thoratec beat expectations on revenues and beat expectations on earnings per share. Compared to Thoratec Beats on Both Top and Bottom Lines
For premium support please call: 800-290-4726 more ways to reach us